Study to Compare Effectiveness and Safety of ABP 501 and Adalimumab (Humira ®) in Adults With Moderate to Severe Plaque Psoriasis
Read time: 1 mins
Last updated:23rd Oct 2013
The purpose of this research study is to compare the effectiveness and safety of ABP 501 and Adalimumab (Humira) in adult subjects with plaque psoriasis.
|Study start date||2013-10-23|